fbpx Skip to main content

As patients with sickle cell disease age, they face comorbidities of pain and multiple organ damage. Preventive and comprehensive care for these patients is often disparate due to a lack of providers who are knowledgeable about the disease, mistrust and stigmatization of those with the disease, and other barriers to care. As a result, adults with sickle cell disease often end up self-managing their condition, only seeking care as a last resort.

Mobile health (mHealth) interventions offer a potential method for supporting the self-management needs of patients with sickle cell disease, as they are low-cost, scalable, and offer great flexibility in design.

To rate how effective a text message-based intervention could be in supporting the self-management of sickle cell disease, researchers developed a novel, high-fidelity prototype of a fully automated mHealth coaching app/chatbot called TREVOR. The researchers used TREVOR to deliver text-based messages and media objects, such as videos and podcasts, in an empathic way to the study’s 33 participants.

TREVOR’s three objectives were to educate patients with evidence-based content on sickle cell disease self-management, educate patients on the self-care practices that other patients have ranked as effective in reducing the incidence of vaso-occlusive pain crises, and provide patients with peer support.

Ultimately, 94% of participants rated TREVOR as fun and easy to use, 88% said it supported patient empowerment, and 82% felt it improved their knowledge about self-management of their condition. This study suggests that chatbots could promote recommended health behaviors and self-care practices for patients with sickle cell disease [1].

Source:

[1] Issom, D. Z., Hardy-Dessources, M. D., Romana, M., Hartvigsen, G., & Lovis, C. (2021). Toward a conversational agent to support the self-management of adults and young adults with sickle cell disease: usability and usefulness study. Frontiers in Digital Health, 3. https://doi.org/10.3389/fdgth.2021.600333

You May Also Like::  The Lesser-Known Complications of Sickle Cell Disease